Polykandriotis E, Arkudas A, Horch R E, Stürzl M, Kneser U
Department of Plastic and Hand Surgery, University of Erlangen Medical Center, Erlangen, Germany.
J Cell Mol Med. 2007 Jan-Feb;11(1):6-20. doi: 10.1111/j.1582-4934.2007.00012.x.
In tissue engineering cell cultures play a crucial role besides the matrix materials for the end of substituting lost tissue functions. The cell itself is situated at the cross-roads leading to different orders of scale, from molecule to organism and different levels of function, from biochemistry to macrophysiology. Extensive in vitro investigations have dissected a vast amount of cellular phenomena and the role of a number of bioactive substances has been elucidated in the past. Further, recombinant DNA technologies allow modulation of the expression profiles of virtually all kinds of cells. However, issues of vascularization in vivo limit transferability of these observations and restrict upscaling into clinical applications. Novel in vivo models of vascularization have evolved inspired from reconstructive microsurgical concepts and they encompass axial neovascularization by means of vascular induction. This work represents a brief description of latest developments and potential applications of neovascularization and angiogenesis in tissue engineering.
在组织工程中,除了用于替代丧失组织功能的基质材料外,细胞培养也起着至关重要的作用。细胞本身处于从分子到生物体的不同尺度级别以及从生物化学到宏观生理学的不同功能水平的交叉点上。过去,广泛的体外研究剖析了大量细胞现象,并阐明了许多生物活性物质的作用。此外,重组DNA技术几乎可以调节所有类型细胞的表达谱。然而,体内血管化问题限制了这些观察结果的可转移性,并限制了向临床应用的扩大规模。受重建显微外科概念启发,新型的体内血管化模型已经出现,它们包括通过血管诱导实现的轴向新生血管形成。这项工作简要描述了组织工程中新生血管形成和血管生成的最新进展及潜在应用。